219 related articles for article (PubMed ID: 30693001)
1. PDL1 Fusion Protein Protects Against Experimental Cerebral Malaria via Repressing Over-Reactive CD8
Wang J; Li Y; Shen Y; Liang J; Li Y; Huang Y; Liu X; Jiang D; Yang S; Zhao Y; Yang K
Front Immunol; 2018; 9():3157. PubMed ID: 30693001
[TBL] [Abstract][Full Text] [Related]
2. Neurons upregulate PD-L1 via IFN/STAT1/IRF1 to alleviate damage by CD8
Wang Y; Shen Y; Liang J; Wang S; Huang Y; Zhu Q; Zhang X; Yu K; Tong G; Yang C; Li Y; Wang J; Zhao Y
J Neuroinflammation; 2024 May; 21(1):119. PubMed ID: 38715061
[TBL] [Abstract][Full Text] [Related]
3. The immunomodulatory effect of microglia on ECM neuroinflammation via the PD-1/PD-L1 pathway.
Shen Y; Li Y; Zhu Q; Wang J; Huang Y; Liang J; Wu X; Zhao Y
CNS Neurosci Ther; 2022 Jan; 28(1):46-63. PubMed ID: 34766463
[TBL] [Abstract][Full Text] [Related]
4. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
Howland SW; Poh CM; Gun SY; Claser C; Malleret B; Shastri N; Ginhoux F; Grotenbreg GM; Rénia L
EMBO Mol Med; 2013 Jul; 5(7):984-99. PubMed ID: 23681698
[TBL] [Abstract][Full Text] [Related]
5. Eosinophils Suppress the Migration of T Cells Into the Brain of
Scheunemann JF; Reichwald JJ; Korir PJ; Kuehlwein JM; Jenster LM; Hammerschmidt-Kamper C; Lewis MD; Klocke K; Borsche M; Schwendt KE; Soun C; Thiebes S; Limmer A; Engel DR; Mueller AK; Hoerauf A; Hübner MP; Schumak B
Front Immunol; 2021; 12():711876. PubMed ID: 34659202
[TBL] [Abstract][Full Text] [Related]
6. Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8
Shaw TN; Inkson CA; Villegas-Mendez A; Pattinson DJ; Strangward P; Else KJ; Draper SJ; Zeef LAH; Couper KN
Front Immunol; 2019; 10():248. PubMed ID: 30846985
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells.
Burrack KS; Huggins MA; Taras E; Dougherty P; Henzler CM; Yang R; Alter S; Jeng EK; Wong HC; Felices M; Cichocki F; Miller JS; Hart GT; Johnson AJ; Jameson SC; Hamilton SE
Immunity; 2018 Apr; 48(4):760-772.e4. PubMed ID: 29625893
[TBL] [Abstract][Full Text] [Related]
8. A
Fernandes P; Howland SW; Heiss K; Hoffmann A; Hernández-Castañeda MA; Obrová K; Frank R; Wiedemann P; Bendzus M; Rénia L; Mueller AK
Front Immunol; 2018; 9():1875. PubMed ID: 30154793
[TBL] [Abstract][Full Text] [Related]
9. Protection of Batf3-deficient mice from experimental cerebral malaria correlates with impaired cytotoxic T-cell responses and immune regulation.
Kuehlwein JM; Borsche M; Korir PJ; Risch F; Mueller AK; Hübner MP; Hildner K; Hoerauf A; Dunay IR; Schumak B
Immunology; 2020 Feb; 159(2):193-204. PubMed ID: 31631339
[TBL] [Abstract][Full Text] [Related]
10. IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.
Guo J; McQuillan JA; Yau B; Tullo GS; Long CA; Bertolino P; Roediger B; Weninger W; Taylor GA; Hunt NH; Ball HJ; Mitchell AJ
Infect Immun; 2015 Apr; 83(4):1406-17. PubMed ID: 25644000
[TBL] [Abstract][Full Text] [Related]
11. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology.
Hafalla JC; Claser C; Couper KN; Grau GE; Renia L; de Souza JB; Riley EM
PLoS Pathog; 2012 Feb; 8(2):e1002504. PubMed ID: 22319445
[TBL] [Abstract][Full Text] [Related]
12. Cross-presentation of malaria antigen by brain microvessels: why CD8(+) T cells are critical for the pathogenesis of experimental cerebral malaria.
Yui K
EMBO Mol Med; 2013 Jul; 5(7):967-9. PubMed ID: 23740752
[No Abstract] [Full Text] [Related]
13. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: selective blockade of LIGHT-lymphotoxin beta receptor signaling protects mice from experimental cerebral malaria caused by Plasmodium berghei ANKA.
Randall LM; Amante FH; Zhou Y; Stanley AC; Haque A; Rivera F; Pfeffer K; Scheu S; Hill GR; Tamada K; Engwerda CR
J Immunol; 2008 Dec; 181(11):7458-62. PubMed ID: 19017933
[TBL] [Abstract][Full Text] [Related]
15. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection.
Miyakoda M; Kimura D; Yuda M; Chinzei Y; Shibata Y; Honma K; Yui K
J Immunol; 2008 Jul; 181(2):1420-8. PubMed ID: 18606696
[TBL] [Abstract][Full Text] [Related]
16. Memory CD8
Shaw TN; Haley MJ; Dookie RS; Godfrey JJ; Cheeseman AJ; Strangward P; Zeef LAH; Villegas-Mendez A; Couper KN
Immunology; 2021 Dec; 164(4):737-753. PubMed ID: 34407221
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
[TBL] [Abstract][Full Text] [Related]
18. CD8
Wang J; Zhu Q; Shen Y; Liang J; Wang Y; Huang Y; Tong G; Wang X; Zhang N; Yu K; Li Y; Zhao Y
CNS Neurosci Ther; 2024 Mar; 30(3):e14431. PubMed ID: 37697956
[TBL] [Abstract][Full Text] [Related]
19. Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis.
Nitcheu J; Bonduelle O; Combadiere C; Tefit M; Seilhean D; Mazier D; Combadiere B
J Immunol; 2003 Feb; 170(4):2221-8. PubMed ID: 12574396
[TBL] [Abstract][Full Text] [Related]
20. Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria.
Haque A; Best SE; Unosson K; Amante FH; de Labastida F; Anstey NM; Karupiah G; Smyth MJ; Heath WR; Engwerda CR
J Immunol; 2011 Jun; 186(11):6148-56. PubMed ID: 21525386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
